During the past decade, Cone Health conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 2 clinical trials were completed, i.e. on average, 22.2% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 2 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Cone Health" #1 sponsor was "Medtronic Cardiac Rhythm and Heart Failure" with 3 trials, followed by "Amgen" with 2 trials sponsored, "CVRx, Inc." with 2 trials sponsored, "Craig Anderson" with 1 trials sponsored and "Reprieve Cardiovascular, Inc" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Cone Health" #1 collaborator was "Duke Clinical Research Institute" with 1 trials as a collaborator, "Duke University" with 1 trials as a collaborator, "Genentech, Inc." with 1 trials as a collaborator, "Johns Hopkins University" with 1 trials as a collaborator and "The George Institute for Global Health, Australia" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Cone Health" are "Heart Failure" (2 trials), "ASCVD" (1 trials), "Acute Decompensated Heart Failure" (1 trials), "Acute Ischemic Stroke Patients Receiving Reperfusion Therapy" (1 trials) and "Atherosclerotic Cardiovascular Disease" (1 trials). Many other conditions were trialed in "Cone Health" in a lesser frequency.

Most popular intervention types in "Cone Health" are "Device" (5 trials), "Other" (4 trials) and "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "BAROSTIM NEO® System" (1 trials), "BATwire Implant Kit" (1 trials), "Control Group (Historical)" (1 trials), "Diuretic" (1 trials) and "Evaluation Group" (1 trials). Other intervention names were less common.

The vast majority of trials in "Cone Health" are 10 trials for "All" genders.

Currently, there are NaN active trials in "Cone Health". undefined are not yet recruiting, 5 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Cone Health, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Cone Health, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 6 trials that are defined as “Not Applicable".